T900607 in Treating Patients With Gastroesophageal Junction Cancer

Completed · Phase 2

Conditions studied: Gastric Cancer

In brief

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of T900607 in treating patients who have gastroesophageal junction cancer.

Key facts

Study ID

NCT00054249

Run by

University Hospitals Seidman Cancer Center

Starts

2002-09-01

Expected to finish

2010-09-01

Last updated by the study team

2013-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ireland Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.